Trained as a clinical psychologist and neuroscientist, Dr. Nicholas’s research focuses on the clinical efficacy and therapeutic mechanisms of psychedelics for mental health conditions, substance use disorders, and pain. He previously served as a site-PI for the Phase 3 Trials of MDMA-assisted therapy for PTSD and his lab often serves as a clinical trial site for sponsored clinical trials. In addition to research, Dr. Nicholas is founding member of the UW Center for Psychedelic Research and Education and faculty with the UW Master’s Program in Psychoactive Pharmaceutical Investigation. He also provides clinical assessment and intervention services for individuals living with chronic pain or HIV and comorbid SUDs; and supervision on psychedelic facilitation, implementation, and harm reduction. Dr. Nicholas earned his Ph.D. in clinical psychology and neuroscience at the University of Tennessee; and completed his post-doctoral fellowship in aging and multi-modal neuroimaging at the University of Wisconsin School of Medicine and Public Health and William S. Middleton VA.